Cedars Sinai
Learn more about our Clinical Trials for Breast Cancer

State-of-the-art Breast Cancer at The Angeles Clinic and Research Institute

Breast Cancer is one of the most common forms of cancer affecting women in both the United States and across the globe. Dr. Cathie Chung is the director of the Breast Cancer Program at the Angeles Clinic and Research Institute. She has over three decades of experience and has contributed to the development of novel and breakthrough therapies which have helped countless patients in their fight against breast cancer. At the Angeles Clinic and Research Institute our clinical team is dedicated to providing our patients with compassionate and personalized therapy prescribed by international oncology experts in breast cancer care. Here, patients have the opportunity to receive care with some of the most advanced treatment, breakthrough clinical trials and diagnostic testing options in the world.

Or use our secure online appointment request form to schedule an appointment at The Angeles Clinic and Research Institute in West Los Angeles and Santa Monica, California.

Breast Cancer

Breast cancer is the second most common form of cancer in women and begins with the development of a cancerous tumor within the breast tissue that grows and can spread (metastasize) across the body. Cancer.org estimates that in 2020 over 276,000 invasive forms of breast cancer will be diagnosed in women with an anticipated 42,000 deaths as a result. Rarely, this cancer also develops in men and there are over 2600 expected cases to be diagnosed in American men in 2020, over 500 of these are anticipated to be fatal.

There are several types of breast cancer and like other forms of cancer early detection and diagnosis is essential to achieve the highest possible chance for a cure. There are several diagnostic tests available for breast cancer screening with mammograms still considered to be the gold standard and self examinations at home are encouraged for women to perform at least monthly. The advancements in screening technology have allowed for patients to receive these services at little to no out of pocket cost.